Prognostic value of baseline
18F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma
来瑞鹤,孙一文,李爱梅,许守林,蒋冲
DOI: https://doi.org/10.3760/cma.j.cn121381-201909020-00100
2020-01-01
Abstract:Objective:To demonstrate whether 18F-fluorodeoxyglucose (FDG) PET/CT metabolic parameters could predict the prognosis of patients with extranodal natural killer/T-cell lymphoma (ENKTL). Methods:Thirty-seven patients, which comprise 27 males and 10 females, with a median age of 46 (21-76) years and newly diagnosed with ENKTL in Nanjing Drum Tower Hospital, were retrospectively analysed. The patients were divided into progression-free group and progression group according to their disease progression status and into survival group and death group according to their survival status. The maximum standardized uptake value (SUV max) of each group was measured. Whole-body metabolic tumor volume (MTV) and whole-body total lesion glycolysis (TLG) were measured automatically using the threshold of 40% SUV max. Mann-Whitney U test was used to evaluate the difference in PET parameters between groups. The optimal critical value of systemic MTV and systemic TLG was obtained by using the receiver operating characteristic curve analysis. The patients were divided into high or low groups according to the optimal critical value of PET parameters. The differences in the overall survival (OS) and progression-free survival (PFS) between groups divided by PET parameters were predicted by Kaplan-Meier method and Log-rank test. Univariate analysis was used to evaluat. Results:The M ( P25, P75) of SUV max, whole-body MTV and whole-body TLG were 10.8 (6.9, 14.4), 13.1 (7.0, 16.7) cm 3 and 53.81 (34.1, 97.4) in the progression-free group and 11.7 (9.5, 17.8), 29.4 (17.3, 69.2) cm 3 and 183.5 (125.1, 725.3) in the progression group, respectively. The SUV max, whole-body MTV and whole-body TLG of the progression group were higher than those of the progression-free group, and the difference was statistically significant ( Z=-2.60, -3.28, -3.25; all P<0.01). The M ( P25, P75) of SUV max, whole-body MTV and whole-body TLG were 9.9 (6.7, 12.7), 10.2 (6.7, 17.1) cm 3 and 52.4 (33.4, 90.4) in the survival group and 12.3 (9.9, 18.7), 25.5 (13.4, 113.6) cm 3 and 187.8 (110.0, 1006.9) in the death group. The SUV max, whole-body MTV and whole-body TLG of the dead group were higher than those of the survival group, and the differences were statistically significant ( Z=-3.37, -3.11, -3.76; all P<0.01). The differences in the OS between the high and low SUV max, whole-body MTV and whole-body TLG groups were statistically significant ( χ2 =5.12, 13.07, 15.51; all P<0.05). The differences in the PFS between the high and low whole-body MTV and whole-body TLG groups were statistically significant ( χ2=17.55, 16.21; both P<0.05). The cut-off values for SUV max , whole-body MTV and whole-body TLG were 9.03, 19.17 cm 3 and 99.95, respectively, according to the receiver operating characteristic curve analysis. Univariate analysis showed that Ann Arbor stage Ⅲ/Ⅳ, Korean prognostic index score>2, SUV max>9.03, wholebody MTV>19.17 cm 3 and whole-body TLG>99.95 were associated with OS, and Ann Arbor stage Ⅲ/Ⅳ stage, whole-body MTV>19.17 cm 3 and whole-body TLG>99.95 were associated with PFS. Multivariate analysis showed that whole-body MTV>19.17 cm 3 and whole-body TLG>99.95 were independent prognostic factors of both OS and PFS.whole-body TLG>99.95 were associated with PFS. Multivariate analysis showed that whole-body MTV>19.17 cm 3 and whole-body TLG>99.95 were independent prognostic factors of both OS and PFS. Conclusion:The 18F-FDG PET/CT metabolic parameters whole-body MTV and whole-body MTV have remarkable prognostic value in patients with ENKTCL, whereas SUV max has little value in prognosis prediction.